Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05607173
What this trial is testing

A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Function Abnormal
Sanofi 21
Testing effectiveness (Phase 2)Looking for participantsNCT07749586
What this trial is testing

Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Arvinas Inc. 499
Early research (Phase 1)Study completedNCT00923520
What this trial is testing

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

Who this might be right for
Renal Cell CarcinomaBreast CancerColon Cancer+2 more
National Cancer Institute (NCI) 60
Early research (Phase 1)UnknownNCT04326296
What this trial is testing

The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
LiNing 33
Early research (Phase 1)Study completedNCT05712889
What this trial is testing

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 29
Early research (Phase 1)Study completedNCT04772989
What this trial is testing

Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more
Arcus Biosciences, Inc. 94
Testing effectiveness (Phase 2)UnknownNCT05830097
What this trial is testing

Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Who this might be right for
Cancer, BreastCancer, LungCancer of Pancreas+2 more
Coherent Biopharma (Hefei) Co., Ltd. 260
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Early research (Phase 1)WithdrawnNCT05028946
What this trial is testing

Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Tiziana Life Sciences LTD
Testing effectiveness (Phase 2)Ended earlyNCT05019742
What this trial is testing

Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shanghai Pharma Biotherapeutics USA Inc. 3
Testing effectiveness (Phase 2)Ended earlyNCT05574010
What this trial is testing

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

Who this might be right for
Celiac Disease
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA 128
Large-scale testing (Phase 3)Study completedNCT01553591
What this trial is testing

Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)

Who this might be right for
Irritable Bowel Syndrome
Furiex Pharmaceuticals, Inc 1,282
Post-approval studies (Phase 4)WithdrawnNCT02485080
What this trial is testing

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1

Who this might be right for
PT-NANBH
Stanford University
Early research (Phase 1)Study completedNCT02173574
What this trial is testing

Two-way Interaction Between Alisporivir and EDP239

Who this might be right for
Hepatitis C Virus
Enanta Pharmaceuticals, Inc 42
Large-scale testing (Phase 3)Study completedNCT02250196
What this trial is testing

Prospective Trial Comparing Low-volume Bowel Preparation Methods

Who this might be right for
Colorectal CancerColon Adenoma
Korea University Anam Hospital 200
Early research (Phase 1)Looking for participantsNCT05433142
What this trial is testing

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Xencor, Inc. 307
Not applicableNot Yet RecruitingNCT06727279
What this trial is testing

Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease NAFLD
Federal State Budgetary Scientific Institution 50
Early research (Phase 1)UnknownNCT04481594
What this trial is testing

Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Hepanova Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00362856
What this trial is testing

Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects

Who this might be right for
Celiac Disease
9 Meters Biopharma, Inc. 80
Testing effectiveness (Phase 2)Looking for participantsNCT06427941
What this trial is testing

BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines 630
Next Page